IRX-101

N/A

Report date: 2026/04/04 20:00:24
NME

Base Information

Drug NameIRX-101
Drug Alias NameIRX101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionRetinal Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesiRenix Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesiRenix Medical Inc
Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsDiabetic macular oedemaRetinal Vein OcclusionGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A